Reversal Agent and Linker Variants of Reversed Chloroquines: Activities against Plasmodium falciparum

被引：117

作者：

Andrews, Simeon ^{[1
]}

Burgess, Steven J. ^{[1
,2
]}

Skaalrud, Deborah ^{[1
]}

Kelly, Jane Xu ^{[1
,2
,3
]}

Peyton, David H. ^{[1
]}

机构：

[1] Portland State Univ, Dept Chem, Portland, OR 97207 USA

[2] DesignMedix Inc, Portland, OR 97201 USA

[3] Portland VA Med Ctr, Portland, OR 97239 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2010年 / 53卷 / 02期

基金：

美国国家科学基金会; 美国国家卫生研究院;

关键词：

BETA-HEMATIN INHIBITION; DRUG-RESISTANCE; MALARIA; ANTIMALARIAL; COMBINATIONS; TRANSPORTER;

D O I：

10.1021/jm900972u

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We have shown that "reversed chloroquine molecules" constructed from chloroquine-like and resistance "reversal-agent"-like cores can be powerful drugs against malaria (J. Med. Chem. 2006, 49, 5623-5625). Several reversed chloroquines are now presented that probe parameters governing the activities against chloroquine-resistant and chloroquine-sensitive malaria strains. The design is tolerant to linker and reversal agent changes, but it piperazinyl group adjacent to the quinoline, at least for the group Of Compounds studied here, may be detrimental.

引用

页码：916 / 919

页数：4

共 19 条

[11] Dihydroethanoanthracene derivatives as in vitro malarial chloroquine resistance reversal agents
Millet, J
Torrentino-Madamet, M
Alibert, S
Rogier, C
Santelli-Rouvier, C
Mosnier, J
Baret, E
Barbe, J
Parzy, D
Pradines, B
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) : 2753 - 2756
[12] Arylpiperazines displaying preferential potency against chloroquine-resistant strains of the malaria parasite Plasmodium falciparum
Molyneaux, CA
Krugliak, M
Ginsburg, H
Chibale, K
[J]. BIOCHEMICAL PHARMACOLOGY, 2005, 71 (1-2) : 61 - 68
[13] Reversed Chloroquines Based on the 3,4-Dihydropyrimidin-2(1H)-one Scaffold: Synthesis and Evaluation for Antimalarial, β-Haematin Inhibition, and Cytotoxic Activity
October, Natasha
Watermeyer, Nicholas D.
Yardley, Vanessa
Egan, Timothy J.
Ncokazi, Kanyile
Chibale, Kelly
[J]. CHEMMEDCHEM, 2008, 3 (11) : 1649 - 1653
[14] Current issues for anti-malarial drugs to control P-falciparum malaria
Schellenberg, D
Abdulla, S
Roper, C
[J]. CURRENT MOLECULAR MEDICINE, 2006, 6 (02) : 253 - 260
[15] Reversal of chloroquine resistance in Plasmodium falciparum using combinations of chemosensitizers
van Schalkwyk, DA
Walden, JC
Smith, PJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) : 3171 - 3174
[16] BISQUINOLINES .1. N,N-BIS(7-CHLOROQUINOLIN-4-YL)ALKANEDIAMINES WITH POTENTIAL AGAINST CHLOROQUINE-RESISTANT MALARIA
VENNERSTROM, JL
ELLIS, WY
AGER, AL
ANDERSEN, SL
GERENA, L
MILHOUS, WK
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (11) : 2129 - 2134
[17] Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine -sensitive and resistant blood-stages of Plasmodium falciparum -: Role of β-haematin inhibition and drug concentration in vacuolar water- and lipid-phases
Warhurst, David C.
Craig, John C.
Adagu, Pemida S.
Guy, R. Kiplin
Madrid, Peter B.
Fivelman, Quinton L.
[J]. BIOCHEMICAL PHARMACOLOGY, 2007, 73 (12) : 1910 - 1926
[18] Overcoming drug resistance to heme-targeted antimalarials by systematic side chain variation of 7-chloro-4-aminoquinolines
Yearick, Kimberly
Ekoue-Kovi, Kekeli
Iwaniuk, Daniel P.
Natarajan, Jayakumar K.
Alumasa, John
de Dios, Angel C.
Roepe, Paul D.
Wolf, Christian
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (07) : 1995 - 1998
[19] The antimalarial drug resistance protein Plasmodium falciparum chloroquine resistance transporter binds chloroquine
Zhang, HB
Paguio, M
Roepe, PD
[J]. BIOCHEMISTRY, 2004, 43 (26) : 8290 - 8296

← 1 2 →